We also tested the predictive potential for TARBP2 and DROSHA to detect ACCs among the 45 potentially malignant adrenocortical tumors after exclusion of tumors with sizes ≤3 cm and the seven patients presenting metastases at diagnosis. Here, TARBP2 is linked to adrenal cortex neoplasm.